Repository logo
 
Publication

Multicentric Study on the Clinical Mycology Capacity and Access to Antifungal Treatment in Portugal

dc.contributor.authorFernandes, Raquel
dc.contributor.authorSabino, Raquel
dc.contributor.authorCunha, Cristina
dc.contributor.authorCornely, Oliver A.
dc.contributor.authorCarvalho, Agostinho
dc.contributor.authorSalmanton‑García, Jon
dc.date.accessioned2025-07-14T11:36:36Z
dc.date.available2025-07-14T11:36:36Z
dc.date.issued2024-01
dc.description.abstractThe success of the clinical management of invasive fungal diseases (IFD) is highly dependent on suitable tools for timely and accurate diagnosis for effective treatment. An in-depth analysis of the ability of European institutions to promptly and accurately diagnose IFD was previously conducted to identify limitations and aspects to improve. Here, we evaluated and discussed the specific case of Portugal, for which, to our knowledge, there are no reports describing the national mycological diagnostic capacity and access to antifungal treatment. Data from 16 Portuguese medical institutions were collected via an online electronic case report form covering different parameters, including institution profile, self-perceived IFD incidence, target patients, diagnostic methods and reagents, and available antifungals. The majority of participating institutions (69%) reported a low-very low incidence of IFD, with Candida spp. indicated as the most relevant fungal pathogen, followed by Aspergillus spp. and Cryptococcus spp. All institutions had access to culture and microscopy, whereas 94 and 88% were able to run antigen-detection assays and molecular tests, respectively. All of the institutions capable of providing antifungal therapy declared to have access to at least one antifungal. However, echinocandins were only available at 85% of the sites. Therapeutic drug monitoring (TDM) was reported to remain a very restricted practice in Portugal, being available in 19% of the institutions, with the TDM of itraconazole and posaconazole performed in only 6% of them. Importantly, several of these resources are outsourced to external entities. Except for TDM, Portugal appears to be well-prepared concerning the overall capacity to diagnose and treat IFD. Future efforts should focus on promoting the widespread availability of TDM and improved access to multiple classes of antifungals, to further improve patient outcomes.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationFernandes, Raquel, et al. «Multicentric Study on the Clinical Mycology Capacity and Access to Antifungal Treatment in Portugal». Mycopathologia, vol. 189, n.o 1, fevereiro de 2024, p. 15. https://doi.org/10.1007/s11046-024-00830-9.pt_PT
dc.identifier.doi10.1007/s11046-024-00830-9pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.5/102153
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringerpt_PT
dc.relationNot Available
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt_PT
dc.subjectPortugalpt_PT
dc.subjectclinical mycologypt_PT
dc.subjectinvasive fungal diseasept_PT
dc.subjectdiagnosispt_PT
dc.subjecttherapypt_PT
dc.subjectantifungalspt_PT
dc.titleMulticentric Study on the Clinical Mycology Capacity and Access to Antifungal Treatment in Portugalpt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.awardTitleNot Available
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/POR_NORTE/2022.12062.BD/PT
oaire.awardURIinfo:eu-repo/grantAgreement/FCT/CEEC IND 2018/CEECIND%2F04058%2F2018%2FCP1581%2FCT0015/PT
oaire.citation.issue1pt_PT
oaire.citation.startPage15pt_PT
oaire.citation.titleMycopathologiapt_PT
oaire.citation.volume189pt_PT
oaire.fundingStreamPOR_NORTE
oaire.fundingStreamCEEC IND 2018
person.familyNameSabino
person.givenNameRaquel Filipa Pinheiro
person.identifier.orcid0000-0001-6585-7775
person.identifier.scopus-author-id35796067600
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.identifierhttp://doi.org/10.13039/501100001871
project.funder.nameFundação para a Ciência e a Tecnologia
project.funder.nameFundação para a Ciência e a Tecnologia
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublication47ebbeef-3e52-47b2-aa6f-def8dd415927
relation.isAuthorOfPublication.latestForDiscovery47ebbeef-3e52-47b2-aa6f-def8dd415927
relation.isProjectOfPublicationf25ae874-ed8c-4591-b056-0554b69b6c3b
relation.isProjectOfPublicationc94e49dc-d498-4ab2-89b4-317f96dd2daf
relation.isProjectOfPublication.latestForDiscoveryf25ae874-ed8c-4591-b056-0554b69b6c3b

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
s11046-024-00830-9.pdf
Size:
529.11 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.2 KB
Format:
Item-specific license agreed upon to submission
Description: